Description
Described as secreting a mouse monoclonal antibody (IgG2akappa) CD23; the cell line was established in 1988 by fusion of PX63AG8.653 cells with spleen cells of a mouse immunized with an EBV-transformed human B cell line from a patient with MHC class II deficiency re-expressing class II antigens